- Report
- May 2024
- 191 Pages
Global
From €3216EUR$3,374USD£2,759GBP
€3573EUR$3,749USD£3,065GBP
- Report
- January 2024
- 200 Pages
Global
From €2373EUR$2,490USD£2,036GBP
- Report
- February 2024
- 175 Pages
Global
From €4766EUR$5,000USD£4,088GBP
- Report
- May 2024
- 194 Pages
Global
From €4718EUR$4,950USD£4,047GBP
- Report
- October 2023
- 172 Pages
Global
From €4670EUR$4,900USD£4,006GBP
- Report
- August 2023
- 85 Pages
United States
From €4527EUR$4,750USD£3,884GBP
- Report
- February 2024
- 112 Pages
Global
From €4527EUR$4,750USD£3,884GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1906EUR$2,000USD£1,635GBP
- Clinical Trials
- April 2024
- 120 Pages
Global
From €1906EUR$2,000USD£1,635GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1430EUR$1,500USD£1,226GBP
- Report
- March 2024
- 238 Pages
Global
From €7577EUR$7,950USD£6,500GBP
- Report
- March 2024
- 119 Pages
Global
From €3765EUR$3,950USD£3,230GBP
- Report
- March 2024
- 199 Pages
Global
From €3216EUR$3,374USD£2,759GBP
€3573EUR$3,749USD£3,065GBP
- Report
- September 2023
- 110 Pages
Global
From €5671EUR$5,950USD£4,865GBP
- Report
- January 2024
- 200 Pages
Global
From €4766EUR$5,000USD£4,088GBP
- Report
- November 2023
- 144 Pages
Global
From €2382EUR$2,499USD£2,043GBP
- Report
- October 2023
- 113 Pages
Global
From €5671EUR$5,950USD£4,865GBP
- Report
- January 2024
- 190 Pages
Global
From €4670EUR$4,900USD£4,006GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4718EUR$4,950USD£4,047GBP
- Report
- November 2020
- 241 Pages
Global
From €3036EUR$3,185USD£2,604GBP
€4337EUR$4,550USD£3,720GBP
The Urinary Tract Infection Drug market is a subset of the Urological Disorders Drugs market. It is composed of drugs used to treat urinary tract infections (UTIs), which are caused by bacteria entering the urinary tract. These drugs are typically antibiotics, such as sulfonamides, cephalosporins, and fluoroquinolones. They are used to kill the bacteria and reduce the symptoms of the infection. Other drugs, such as antifungals, may also be used to treat UTIs.
The Urinary Tract Infection Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, Sanofi, and Novartis. These companies are constantly developing new drugs to treat UTIs, as well as other urological disorders. Show Less Read more